About
Avisi Technologies develops nanotechnology-enabled medical devices and drug delivery platforms aimed at lowering intraocular pressure in patients with open-angle glaucoma, with products including its flagship VisiPlate aqueous shunt.
Explore Avisi Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.